The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision
暂无分享,去创建一个
A. Hochberg | I. Matouk | David Halle | D. Halle | Eli Raveh | Michal Gilon | V. Sorin | Michal Gilon | Imad J. Matouk | Eli Raveh | Vladimir Sorin | Avraham Hochberg | E. Raveh
[1] S. Rafii,et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.
[2] F Poirier,et al. The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. , 1991, Development.
[3] A. Hochberg,et al. Treatment of ovarian cancer ascites by intra-peritoneal injection of diphtheria toxin A chain-H19 vector: a case report , 2010, Journal of medical case reports.
[4] J. Pollard,et al. Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.
[5] Richard O Hynes,et al. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. , 2011, Cancer cell.
[6] A. Hochberg,et al. H19-Promoter-Targeted Therapy Combined with Gemcitabine in the Treatment of Pancreatic Cancer , 2012, ISRN oncology.
[7] G. Goodall,et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.
[8] T. Kwok,et al. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells , 2007, Oncogene.
[9] T. Brabletz,et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells , 2008, EMBO reports.
[10] H. Xia,et al. Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells. , 2016, Journal of neurosurgery.
[11] Jiejie Xu,et al. Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E‐cadherin in renal cell carcinoma , 2016, BJU international.
[12] A. Hochberg,et al. The H19 Non-Coding RNA Is Essential for Human Tumor Growth , 2007, PloS one.
[13] A. Kolokythas,et al. Polycomb group protein EZH2‐mediated E‐cadherin repression promotes metastasis of oral tongue squamous cell carcinoma , 2013, Molecular carcinogenesis.
[14] Debashis Ghosh,et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[15] H. Taylor,et al. Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation , 2014, Oncogene.
[16] C. Heldin,et al. Transforming growth factor-β employs HMGA2 to elicit epithelial–mesenchymal transition , 2006, The Journal of cell biology.
[17] T. Sellers,et al. Long Non-coding RNAs (LncRNA) Regulated by Transforming Growth Factor (TGF) β , 2015, The Journal of Biological Chemistry.
[18] A. Hochberg,et al. Regional therapy with DTA-H19 vector suppresses growth of colon adenocarcinoma metastases in the rat liver. , 2011, International journal of oncology.
[19] L. Hornez,et al. Cross-talk between mesenchyme and epithelium increases H19 gene expression during scattering and morphogenesis of epithelial cells. , 2002, Experimental cell research.
[20] John T. Wei,et al. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. , 2014, The Lancet. Oncology.
[21] Dan Liu,et al. PI3 kinase/Akt/HIF-1α pathway is associated with hypoxia-induced epithelial–mesenchymal transition in fibroblast-like synoviocytes of rheumatoid arthritis , 2012, Molecular and Cellular Biochemistry.
[22] Maximilian Reichert,et al. EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.
[23] P. Wade,et al. Aberrant Expression of the Transcription Factors Snail and Slug Alters the Response to Genotoxic Stress , 2004, Molecular and Cellular Biology.
[24] J. Hsieh,et al. Down-regulation of Human DAB2IP Gene Expression Mediated by Polycomb Ezh2 Complex and Histone Deacetylase in Prostate Cancer* , 2005, Journal of Biological Chemistry.
[25] Yu-qin Pan,et al. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway , 2015, Oncotarget.
[26] Hiroyuki Aburatani,et al. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis , 2006, Nature Cell Biology.
[27] Anindya Dutta,et al. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. , 2007, Genes & development.
[28] M. Reginato,et al. Hypoxia Suppression of Bim and Bmf Blocks Anoikis and Luminal Clearing during Mammary Morphogenesis , 2010, Molecular biology of the cell.
[29] C. Heldin,et al. HMGA2 and Smads Co-regulate SNAIL1 Expression during Induction of Epithelial-to-Mesenchymal Transition* , 2008, Journal of Biological Chemistry.
[30] G. Christofori,et al. Hepatocyte growth factor induces cell scattering through MAPK/Egr‐1‐mediated upregulation of Snail , 2006, The EMBO journal.
[31] Piotr J. Balwierz,et al. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. , 2013, Cancer cell.
[32] Julien Pontis,et al. H19 lncRNA controls gene expression of the Imprinted Gene Network by recruiting MBD1 , 2013, Proceedings of the National Academy of Sciences.
[33] P. Schlag,et al. Resection and local therapy for liver metastases. , 2002, Best practice & research. Clinical gastroenterology.
[34] Ning Liu,et al. Long Non-Coding RNA H19 Promotes Glioma Cell Invasion by Deriving miR-675 , 2014, PloS one.
[35] A. Gabory,et al. The H19 locus acts in vivo as a tumor suppressor , 2008, Proceedings of the National Academy of Sciences.
[36] Yakov Fellig,et al. Transcriptional targeting of glioblastoma by diphtheria toxin-A driven by both H19 and IGF2-P4 promoters. , 2012, International journal of clinical and experimental medicine.
[37] Howard Y. Chang,et al. Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.
[38] Ming Sun,et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer , 2014, Molecular Cancer.
[39] A. G. de Herreros,et al. A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. , 2008, Genes & development.
[40] R. Kong,et al. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial–mesenchymal transition , 2014, Cell Death and Disease.
[41] M. Nakao,et al. HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells. , 2009, The American journal of pathology.
[42] Yu-qin Pan,et al. Up-Regulation of 91H Promotes Tumor Metastasis and Predicts Poor Prognosis for Patients with Colorectal Cancer , 2014, PloS one.
[43] C. Croce,et al. p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2 , 2011, The Journal of experimental medicine.
[44] G. Bell,et al. Fundamental differences in endoreplication in mammals and Drosophila revealed by analysis of endocycling and endomitotic cells , 2013, Proceedings of the National Academy of Sciences.
[45] Tae Jin Lee,et al. p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2 , 2011, The Journal of experimental medicine.
[46] Qingqing Cai,et al. linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer. , 2013, Biochimica et biophysica acta.
[47] A. Hochberg,et al. H19 expression in hepatic metastases from a range of human carcinomas , 2005, Journal of Clinical Pathology.
[48] Jun Yu,et al. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. , 2010, Carcinogenesis.
[49] L. Orci,et al. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor , 1991, Cell.
[50] K. Hua,et al. Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion/metastasis in serous ovarian cancer. , 2015, International journal of oncology.
[51] Ker-Chau Li,et al. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug , 2009, Nature Cell Biology.
[52] V. Erdmann,et al. Detection of oncofetal h19 RNA in rheumatoid arthritis synovial tissue. , 2003, The American journal of pathology.
[53] R. Weinberg,et al. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis , 2014, Nature Cell Biology.
[54] E. Thompson,et al. Targeting EMT in cancer: opportunities for pharmacological intervention. , 2014, Trends in pharmacological sciences.
[55] Xuefei Shi,et al. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma , 2015, Oncotarget.
[56] J. Lieberman,et al. miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases , 2009, PloS one.
[57] A. Hochberg,et al. The Increasing Complexity of the Oncofetal H19 Gene Locus: Functional Dissection and Therapeutic Intervention , 2013, International journal of molecular sciences.
[58] Abraham Hochberg,et al. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis , 2009, European journal of gastroenterology & hepatology.
[59] H. Pehamberger,et al. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. , 2004, The Journal of clinical investigation.
[60] L. Doyle,et al. H19 gene overexpression in atypical multidrug-resistant cells associated with expression of a 95-kilodalton membrane glycoprotein. , 1996, Cancer research.
[61] T. Graeber,et al. Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. , 1997, Cancer research.
[62] T. Brabletz. To differentiate or not — routes towards metastasis , 2012, Nature Reviews Cancer.
[63] Abraham Hochberg,et al. The non-coding RNAs of the H19-IGF2 imprinted loci: A focus on biological roles and therapeutic potential in Lung Cancer , 2015, Journal of Translational Medicine.
[64] Gema Moreno-Bueno,et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.
[65] A. Hochberg,et al. Oncofetal H19 RNA promotes tumor metastasis. , 2014, Biochimica et biophysica acta.
[66] David P. Bartel,et al. Supporting Online Material Materials and Methods Fig. S1 Tables S1 and S2 References Database S1 Disrupting the Pairing between Let-7 and Hmga2 Enhances Oncogenic Transformation , 2022 .
[67] A. Hochberg,et al. Possible physiological role of H19 RNA , 2002, Molecular carcinogenesis.
[68] J. Coll,et al. The H19 gene is expressed within both epithelial and stromal components of human invasive adenocarcinomas , 1995, Biology of the cell.
[69] H. Yao,et al. A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis. , 2015, Cancer cell.
[70] Wei Chen,et al. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer , 2015, Molecular Cancer.
[71] F. Liu,et al. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. , 2014, Cancer cell.
[72] A. Hochberg,et al. The oncofetal H19 RNA connection: hypoxia, p53 and cancer. , 2010, Biochimica et biophysica acta.
[73] Rui Xia,et al. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition , 2014, Molecular Cancer.
[74] A. Hochberg,et al. Parallel regulation of parentally imprinted H19 and insulin-like growth factor-II genes in cultured human fetal adrenal cells. , 1994, Endocrinology.
[75] Andreas Sommer,et al. NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression , 2004 .
[76] Yoko Matsuda,et al. Abstract 5203: Long non-coding RNA H19 as a novel therapeutic target for pancreatic cancer , 2014 .
[77] Shuhan Sun,et al. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. , 2013, Carcinogenesis.
[78] Anindya Dutta,et al. The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration , 2014, Genes & development.
[79] C. Cordon-Cardo,et al. Autocrine PDGFR signaling promotes mammary cancer metastasis. , 2006, The Journal of clinical investigation.
[80] David E. Housman,et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.
[81] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[82] A. Nakagawara,et al. Hypoxia selects for high-metastatic Lewis lung carcinoma cells overexpressing Mcl-1 and exhibiting reduced apoptotic potential in solid tumors , 2006, Oncogene.
[83] V. Iotsova,et al. The H19 TATA-less promoter is efficiently repressed by wild-type tumor suppressor gene product p53 , 1998, Oncogene.
[84] C. Rüegg,et al. Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes. , 2012, Cancer discovery.
[85] C. Michiels,et al. Reciprocal influence of the p53 and the hypoxic pathways , 2011, Cell Death and Disease.
[86] A. Hochberg,et al. Partial Hepatectomy in rats results in significant growth of liver metastases by increased expression of H19 gene , 2009 .
[87] Chaochun Liu,et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. , 2013, Molecular cell.
[88] A. Rangarajan,et al. Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters , 2011, Cell Death and Disease.
[89] A. Hochberg,et al. Regulatory sequences of H19 and IGF2 genes in DNA‐based therapy of colorectal rat liver metastases , 2005 .
[90] Huamin Wang,et al. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. , 2009, Cancer research.
[91] D. Reinberg,et al. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. , 2010, Genes & development.
[92] A. Andreeva,et al. Cadherin 13 in cancer , 2010, Genes, chromosomes & cancer.
[93] A. Hochberg,et al. Transcription of the H19 gene in differentiating cytotrophoblasts from human placenta , 1992, Molecular reproduction and development.
[94] Rajvir Dahiya,et al. Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. , 2015, Cancer research.
[95] C. Dai,et al. Mechanism of the Mesenchymal–Epithelial Transition and Its Relationship with Metastatic Tumor Formation , 2011, Molecular Cancer Research.
[96] J. Settleman,et al. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer , 2010, Oncogene.
[97] H. Li,et al. Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma , 2015, Oncogene.
[98] Michael F. Clarke,et al. Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.
[99] Charles H. Graham,et al. Hypoxia-driven selection of the metastatic phenotype , 2007, Cancer and Metastasis Reviews.
[100] T. Yeatman,et al. miR-675 Mediates Downregulation of Twist1 and Rb in AFP-Secreting Hepatocellular Carcinoma , 2013, Annals of Surgical Oncology.
[101] Zhou Yuan,et al. H19 promotes pancreatic cancer metastasis by derepressing let-7’s suppression on its target HMGA2-mediated EMT , 2014, Tumor Biology.
[102] D. Lamm,et al. Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin. , 2008, The Journal of urology.
[103] B. Cullen,et al. The imprinted H19 noncoding RNA is a primary microRNA precursor. , 2007, RNA.
[104] Ming Sun,et al. Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a , 2014, Oncotarget.
[105] M. Jo,et al. Reversibility of Epithelial-Mesenchymal Transition (EMT) Induced in Breast Cancer Cells by Activation of Urokinase Receptor-dependent Cell Signaling* , 2009, The Journal of Biological Chemistry.
[106] Christian Ruiz,et al. Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients , 2014, Hepatology.
[107] Bangshun He,et al. Long non‐coding RNA 91H contributes to the occurrence and progression of esophageal squamous cell carcinoma by inhibiting IGF2 expression , 2015, Molecular carcinogenesis.
[108] Yiping Huang,et al. Long Noncoding RNA H19 Promotes Osteoblast Differentiation Via TGF‐β1/Smad3/HDAC Signaling Pathway by Deriving miR‐675 , 2015, Stem cells.
[109] W Abou-Kheir,et al. MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms , 2013, Oncogene.